We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Abbott and Cerner to Develop Safer Infusion System

By HospiMedica staff writers
Posted on 15 May 2003
An exclusive agreement to develop and co-market a safer new point-of-care (POC) medication-management system for infusion therapy has been announced by Abbott Laboratories (Abbott Park, IL, USA) and Cerner Corp. More...
(Kansas City, MO, USA).

The system will integrate POC infusion and diagnostic medical devices, bar coding, clinical information, and decision-support tools at the patient's bedside to improve safety, clinical outcomes, and cost management. Initially, the system will aim to improve safety in fusion therapy through a secure identification of the caregiver, patient, device, and IV access site matched with doctor orders, patient-assessment parameters, patient medical history, and hospital-specific best-practice treatment protocols. The system will then be enhanced to include Cerner's software, called Cerner Millennium solutions.

These solutions comprise an integration tool kit, a drug information database, computerized doctor-order entry system, pharmacy information system, and electronic medical record. These will be combined with Abbot's POC diagnostic devices, including its infusion therapy pumps. The system will interface with most hospital information systems and medical devices. Additional functionality may be added for more complex therapeutic applications and clinical specialties.

"The collaboration between our two companies will accelerate the development of software products that provide solutions for therapies with the highest potential for error,” said John Arnott, vice president, hospital business sector, Abbott.





Related Links:
Abbott
Cerner Corp

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Infant Incubator
OKM 801
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.